The Deadly Fungus-A Case Series of Rhino-Facial Mucormycosis in Uncontrolled Diabetes

Download Article

DOI: 10.21522/TIJPH.2013.12.03.Art033

Authors : S. Srismitha, M. Preethi, Sanjana S, Mary Lilly

Abstract:

Mucormycosis is more common in conditions like uncontrolled diabetes  Fungal infection invades body through inhalation of spores by nose /mouth or by skin laceration. Successful management of the deadly fatal infection requires early diagnosis of the disease and proper management for the aggressive disease. We hereby report a case of mucormycosis of the maxillary sinus in an uncontrolled diabetic patient. 47-year-old male complaints of facial pain, nasal block  and headache . ENT examination revealed DNS to right with spur, left middle turbinate shows fungal debris with purulent discharge and middle meatus appears normal. Investigations revealed FBS 184 mg/dl  and PBS 267 mg/dl .  FESS surgery done and the specimen show Microscopically - mucormycosis. 52-year-old male chief complaints of headache , toothache and nasal block. ENT DNS to right, left middle turbinate hypertrophy with necrotic debris. FBS 289 mg/dl and PBS 380 mg/dl . FESS surgery done and the specimen was reported mucormycosis. A 48-year-old female chief complaints of bleeding nose,  fever, nasal blockade and headache . ENT show DNS left with middle turbinate hypertrophy. FBS 214 mg/dl  and PPBS 304 mg/dl .FESS surgery done, and the specimen was reported as mucormycosis. PAS stain show fungal hyphae. deadly fungal infection mucormycosis, Early detection and diagnosis of a such a dangerous invasive infection and proper management at the right time is essential for the overall survival and outcome for the patient.

References:

[1]. Viterbo, S., Fasolis, M., Garzino-Demo, P., Griffa, A., Boffano, P., Iaquinta, C., Tanteri, G., & Modica, R., 2011, Management and Outcomes of Three Cases of Rhinocerebral Mucormycosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 112(6), 69-74. https://doi.org/10.1016/j.tripleo.2011.06.006
[2]. Torres-Narbona, M., Guinea, J., Muñoz, P., & Bouza, E., 2007, Zygomycetes and zygomycosis in the New Era of Antifungal Therapies. Revista Española de Quimioterapia: Publicación Oficial de la Sociedad Española de Quimioterapia, 20(4), 375-386.
[3]. Goel, S., Palaskar, S., Shetty, V. P., & Bhushan, A., 2009, Rhinomaxillary Mucormycosis with Cerebral Extension. Journal of Oral and Maxillofacial Pathology, 13(1), 14-17.
[4]. Salisbury III, P. L., Caloss, Jr, R., Cruz, J. M., Powell, B. L., Cole, R., & Kohut, R., 1997, Mucormycosis of the Mandible After Dental Extractions In A Patient With Acute Myelogenous Leukemia. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 83(3), 340-344.
[5]. Neville, B. W., Damm, D. D., Allen, C. M., & Bouquot, J. E., 1990, Textbook of Oral And Maxillofacial Pathology (2nd ed., 4th printing). W. B. Saunders Company. 
[6]. Mohindra, S., Mohindra, S., Gupta, R., Bakshi, J., & Gupta, S. K., 2007, Rhinocerebral mucormycosis: The Disease Spectrum in 27 patients. Mycoses, 50(4), 290-296.
[7]. Bakathir, A. A., 2006, Mucormycosis of The Jaw After Dental Extractions: Two Case Reports. Sultan Qaboos University Medical Journal, 6(2), 77-80.
[8]. Marx, R. E., & Stern, D., 2003, Inflammatory, Reactive, And Infectious Diseases In Oral And Maxillofacial Pathology. Carol Stream, IL. (pp. 104-106).
[9]. Kajs-Wyllie, M., 1995, Hyperbaric Oxygen Therapy for Rhinocerebral Fungal Infection. Journal of Neuroscience Nursing, 27(3), 174-181.
[10]. Lador, N., Polacheck, I., Gural, A., Sanatski, E., & Garfunkel, A., 2006, A Trifungal Infection of the Mandible: Case Report And Literature Review. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 101(4), 451-456.
[11]. Artis, W. M., Fountain, J. A., Delcher, H. K., & Jones, H. E., 1982, A Mechanism of Susceptibility To Mucormycosis in Diabetic Ketoacidosis: Transferrin and Iron Availability. Diabetes, 31(12), 1109-1114.
[12]. Castrejón-Pérez, A. D., Welsh, E. C., Miranda, I., Ocampo-Candiani, J., & Welsh, O., 2017, Cutaneous mucormycosis. Anais Brasileiros de Dermatologia, 92(3), 304-311.
[13]. Spellberg, B., Edwards, J. R., & Ibrahim, A., 2005, Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, AND Management. Clinical Microbiology Reviews, 18(3), 556-569.
[14]. Kim, J., Fortson, J. K., & Cook, H. E., 2001, A Fatal Outcome from Rhinocerebral Mucormycosis after Dental Extractions: A Case Report. Journal of Oral and Maxillofacial Surgery, 59(6), 693-697.
[15]. Doni, B. R., Peerapur, B. V., Thotappa, L. H., & Hippargi, S. B., 2011, Sequence of Oral Manifestations In Rhino-Maxillary Mucormycosis. Indian Journal of Dental Research, 22(2), 331-335.
[16]. Mortazavi, H., Safi, Y., Baharvand, M., Jafari, S., Anbari, F., & Rahmani, S., 2019, Oral White Lesions: An Updated Clinical Diagnostic Decision Tree. Dentistry Journal, 7(1), 15.
[17]. Meshram, H. S., Kute, V. B., Chauhan, S., & Desai, S., 2021, Mucormycosis in post-COVID-19 Renal Transplant Patients: A Lethal Complication In Follow-Up. Transplant Infectious Disease, 23(4). https://doi.org/10.1111/tid.13668
[18]. Shah, D., Talwar, D., Kumar, S., Acharya, S., & Dubey, A., 2021, Mucormycosis as a Complication of Long COVID: A Case Series. Medical Science, 25(112), 1331-1337.
[19]. Karimi-Galougahi, M., Arastou, S., & Haseli, S., 2021, Fulminant Mucormycosis Complicating Coronavirus Disease 2019 (COVID-19). International Forum of Allergy & Rhinology, 11(6), 1001-1006. https://doi.org/10.1002/alr.22792
[20]. Karimi-Galougahi, M., Arastou, S., & Haseli, S., 2021, Fulminant Mucormycosis Complicating Coronavirus Disease 2019 (COVID-19). International Forum of Allergy & Rhinology, 11(6), 1001-1006. https://doi.org/10.1002/alr.22792
[21]. Veisi, A., Bagheri, A., Eshaghi, M., Rikhtehgar, M. H., Rezaei Kanavi, M., & Farjad, R., 2022, Rhino-orbital Mucormycosis During Steroid Therapy in COVID-19 Patients: A Case Report. European Journal of Ophthalmology, 32(4), NP11-NP16. https://doi.org/10.1177/11206721221105167